Navigation Links
Phase II trails of new HIV vaccine to be held in South Africa

In a step further to combat the AIDS epidemic, South Africa's first Phase II HIV vaccine trials were launched by charitable group the International AIDS Vaccine Initiative (IAVI) and U.S.-based Targeted Genetics Corporation. //

The trials will test the safety of "tgAAC09" is a preventive HIV vaccine candidate that is based on HIV subtype C, the subtype of the virus most prevalent in southern and eastern Africa, the two groups said in a joint statement on Monday.

Sub-Saharan Africa is the region hardest hit by AIDS, with more than 25 million people estimated to be infected with HIV, the virus that leads to the disease.

South Africa has the highest caseload of HIV in the world, with about one in nine of its 45 million population carrying the virus, while in neighbouring Botswana and Swaziland prevalence is as high as 40 percent.

"We are pleased that South Africa has taken a leading role in the testing of vaccine candidates given the medical and humanitarian promise a preventative vaccine holds," said Eftyhia Vardas, a doctor at the country's Perinatal HIV Research Unit, who will coordinate the trials.

Investigators test the immune response and acquire more data on safety during second phase trials on drugs that have already been proven safe during first phase tests. tgAAC09 is designed to elicit two different types of immune responses, an antibody response and a cell mediated response. The vaccine consists of an artificially made copy of the HIV virus and cannot cause HIV infection or Aids," the IAVI said on Monday.

The vaccine candidate, developed by U.S.-based Targeted Genetics, will be tested on 78 healthy volunteers at three sites in South Africa. The trial is expected to last 18 months.

IAVI, a global non-profit organisation working to accelerate the development of an AIDS vaccine, estimates that around 30 preventative HIV vaccine candidates are in human trials in six continents.

The South African trial follows positive safety data received from "Phase I" tests conducted over the past two years in Belgium, Germany and India.

This is the first Phase II HIV vaccine trial to be held in South Africa.


'"/>




Related medicine news :

1. SARS-Free Taiwan to Mark End Phase of Global Fight
2. Spray on contraceptive clears Phase I trial
3. Phase 3 trials of two multi-kinase inhibitors against cancer
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. FDA approves Phase 0 trial which tests experimental drugs on humans
6. Jalgaon: Third Phase Of Culling Operations Begin
7. Phase 1 Drug Trials on Humans to Be Made Public
8. Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P
9. Cadila to Commence Phase I Clinical Trials On ZYH2
10. iGATE Completes Phase I Testing Of Meningitis Vaccine
11. ADHD Treatment -Phase 3 data on Lisdexamfetamine dimesylate Presented
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2020)... ... September 02, 2020 , ... ... healthcare payers administering Medicare Advantage and Special Needs plans, is proud to support ... Health Insurance Plans (AHIP). RAM is supporting the event as a sponsor and ...
(Date:9/1/2020)... ... September 01, 2020 , ... KitoTech Medical, ... convertible note financing, which will be used to accelerate the commercialization of its ... financing, the company will continue to expand its customer base of healthcare systems ...
(Date:9/1/2020)... Calif. (PRWEB) , ... September 01, 2020 , ... As ... “safe side”, the Cohn Health Institute has taken this time to expand ... celebration of its 30th Anniversary, the Cohn Health Institute will be relaunching its brand ...
(Date:8/31/2020)... PITTSBURGH (PRWEB) , ... August 31, 2020 , ... ... Allegheny Health Network (AHN), are joining biomedical engineers from Carnegie Mellon University (CMU) ... alternative for cardiac patients who have undergone open heart surgery. , The AGH/CMU ...
(Date:8/31/2020)... CHESTER, N.J. (PRWEB) , ... August 31, 2020 , ... Just found out your dear ... cancer.” It’s heartbreaking when your friend or family member shares their diagnosis. Once the shock ... if I say the wrong thing? What are the best ways to help? Words are ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... 31, 2020 , ... Continuing on its rapid national expansion ... and deodorization provider - is proud to announce it has opened doors in ... and residents throughout the area. , Germinator provides a 100% safe and non-toxic ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... today announced the successful completion of their 2020 System and Organizational Controls (SOC) ... HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect their long-standing commitment ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bridge To A Cure Foundation announces the ... adult and pediatric neuro-oncologist who serves on the Board of Directors at The Preston ... University Medical School. , Internationally recognized, Dr. Friedman is a widely published author of ...
Breaking Medicine Technology: